info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Interleukin Inhibitors Market By Type (IL-1, IL-6, IL-17, IL-23, IL-12/23, IL-4/13, Others); By Indication (Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease, Asthma, Atopic Dermatitis, Others); By Route of Administration (Subcutaneous, Intravenous, Oral); By End User (Hospitals, Specialty Clinics, Homecare, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Interleukin Inhibitors Market will witness a robust CAGR of 10.2% , valued at $22.8 billion in 2024 , expected to appreciate and reach $45.4 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485
Bipolar Disorder Treatment Market By Drug Class (Mood Stabilizers, Atypical Antipsychotics, Anticonvulsants, Antidepressants, Others); By Route of Administration (Oral, Parenteral, Transdermal); By End User (Hospitals, Outpatient Clinics, Private Practices, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bipolar Disorder Treatment Market will witness a robust CAGR of 6.8 % , valued at $7.4 billion in 2024 , expected to appreciate and reach $10.9 bi... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485
Lymphoma Treatment Market By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Stem Cell Transplantation); By Disease Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Cancer Centers, Academic and Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lymphoma Treatment Market will witness a robust CAGR of 9.3 % , valued at $12.4 billion in 2024 , and is expected to appreciate and reach... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485
Congestive Heart Failure (CHF) Drugs Market Congestive Heart Failure Drugs Market By Drug Class (ACE Inhibitors, Beta-Blockers, Diuretics, ARNIs, SGLT2 Inhibitors, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congestive Heart Failure ( CHF ) Drugs Market will witness a steady CAGR of 5.8% , valued at approximately $14.2 billion in 2024<... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485
Food Allergy Treatment Market By Treatment Type (Oral Immunotherapy, Epinephrine Auto-injectors, Biologics, Antihistamines); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By End User (Hospitals, Clinics, Allergy Specialty Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Food Allergy Treatment Market will witness a robust CAGR of 9.1% , valued at $2.41 billion in 2024 , expected to appreciate and reach $4.07 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485
Blastic Plasmacytoid Dendritic Cell Neoplasm Market By Treatment Type (Chemotherapy Regimens, Targeted Therapies, Immunotherapies); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals and Oncology Centers, Specialty Clinics, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blastic Plasmacytoid Dendritic Cell Neoplasm ( BPDCN ) Market will witness a robust CAGR of 8.7% , valued at USD... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485
Hunter Syndrome Treatment Market By Treatment Type (Enzyme Replacement Therapy, Gene Therapy, Substrate Reduction Therapy, Supportive & Symptomatic Treatment); By Route of Administration (Intravenous, Intrathecal, Oral, Others); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hunter Syndrome Treatment Market will witness a robust CAGR of 7.4% , valued at $1.21 billion in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485
Paracetamol Intravenous (IV) Market By Formulation Type (Standard Vial Injection, Ready-to-Use Infusion Bag, Ampoule-Based Formulations); By Application (Postoperative Pain Management, Fever Reduction in Critical Care, Trauma and Emergency Care); By End User (Hospitals, Ambulatory Surgical Centers, Emergency Departments and ICUs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paracetamol Intravenous ( IV ) Market will witness a robust CAGR of 5.8% , valued at approximately $785 million in 2024 , and is expected... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485
Hepatitis Therapeutics Market By Drug Class (Direct-Acting Antivirals, Nucleos(t)ide Analogues, Immune Modulators, Combination Therapies); By Disease Type (Hepatitis B, Hepatitis C, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hepatitis Therapeutics Market will witness a robust CAGR of 6.8% valued at , $17.4 billion in 2024 , expected to appreciate and reach $25.9 billio... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485
Phenylketonuria (PKU) Treatment Market By Treatment Type (Medical Foods, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatments); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Phenylketonuria ( PKU ) Treatment Market will witness a robust CAGR of 6.5% , valued at $1.2 bi... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485
Lysosomal Acid Lipase Deficiency Treatment Market By Therapy Type (Enzyme Replacement Therapy, Gene Therapy, Adjunctive Therapies); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Specialty Clinics, Hospitals, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Lysosomal Acid Lipase Deficiency Treatment Market will witness a robust CAGR of 10.4% , valued at $425 million in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485
Digestive and Intestinal Remedies Market By Product Type (Antacids, Laxatives, Anti-diarrheal Agents, Probiotics and Prebiotics, Digestive Enzymes, IBS/IBD-Specific Therapies, Herbal and Natural Remedies); By Disease Indication (Constipation, Diarrhea, GERD, IBS, IBD, Lactose Intolerance, Gut Health Maintenance); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Supermarkets, Health & Wellness Stores); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digestive And Intestinal Remedies market will witness a robust CAGR of 6.4% , valued at $42.7 billion in 2024 , expected to apprecia... Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485
Non-Opioid Pain Patches Market By Product Type (Lidocaine, Capsaicin, Diclofenac, Ketoprofen, Menthol-Based, Others); By Application (Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Post-Surgical Pain, Sports Injuries, Others); By End User (Hospitals & Surgical Centers, Retail Pharmacies, Online Pharmacies, Home Healthcare, Rehabilitation Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Opioid Pain Patches Market will witness a promising CAGR of 8.2 %, valued at $3.1 billion in 2024 , and is expected to appreciate and... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485
Antipsychotic Drugs Market By Drug Type (Typical, Atypical); By Therapeutic Application (Schizophrenia, Bipolar Disorder, Major Depressive Disorder With Psychotic Features, Other Psychoses); By Route of Administration (Oral, Long-Acting Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antipsychotic Drugs Market will witness a robust CAGR of 4.6 % , valued at USD 16.2 billion in 2024, expected to appreciate and reach USD... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485
Amyotrophic Lateral Sclerosis Treatment Market By Treatment Type (Medication-Based Therapy, Gene and Cell Therapy, Symptomatic Treatment); By Route of Administration (Oral, Intravenous, Subcutaneous, Others); By End User (Hospitals, Specialized Neurology Clinics, Homecare Settings, Research and Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Amyotrophic Lateral Sclerosis ( ALS ) Treatment Market will witness a robust CAGR of 8.4% , valued at $1.26 billion in 2024 , expected to... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485
Autoimmune Hemolytic Anemia (AIHA) Treatment Market By Treatment Type (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Blood Transfusions, Surgical Interventions, Complement Inhibitors); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Autoimmune Hemolytic Anemia ( AIHA ) Treatment Market will witness a robust CAGR of 7.1% , valued at Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485
Omega-3 Prescription Drugs Market By Product Type (EPA-Only Formulations, Combination EPA/DHA Formulations); By Application (Severe Hypertriglyceridemia, Cardiovascular Event Risk Reduction, Other Emerging Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Specialty Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Omega-3 Prescription Drugs Market will witness a robust CAGR of 6.4% , valued at $2.1 billion in 2024, expected to appreciate and reach $3.1 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485
Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Tumor Necrosis Factor Inhibitor Drugs Market By Product Type (Monoclonal Antibodies, Fusion Proteins, Biosimilars); By Route of Administration (Subcutaneous, Intravenous); By Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Psoriasis, Ulcerative Colitis, Others); By End User (Hospitals & Specialty Clinics, Ambulatory Infusion Centers, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tumor Necrosis Factor Inhibitor Drugs Market will witness a robust CAGR of 7.1% , valued at approximately USD 36.7 Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485
Age-Related Macular Degeneration Market By Disease Type (Dry AMD, Wet AMD); By Drug Class (Anti-VEGF Agents, Complement Inhibitors, Gene Therapy, Others); By Route of Administration (Intravitreal, Oral, Subretinal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Age-Related Macular Degeneration ( AMD ) Market will witness a robust CAGR of 6.8% , valued at approximately $9.4 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485
Oncology-Based In Vivo CRO Market By Service Type (Preclinical In Vivo Studies, Pharmacokinetics / Pharmacodynamics Studies, Toxicology Studies, Efficacy Studies); By Oncology Type (Solid Tumors, Hematologic Malignancies); By Phase (Preclinical, Phase I, Phase II, Phase III); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oncology-Based In Vivo CRO Market will witness a robust CAGR of 9.2% , valued at $1.85 billion in 2024 , expected to appreciate and reach... Read More

Published Date: OCT-2025 | No Of Pages:191 | $ 4485
Basal Cell Carcinoma (BCC) Treatment Market By Treatment Type (Surgical Procedures, Topical Medications, Targeted Therapies, Radiation Therapy, Immunotherapy); By Route of Administration (Topical, Oral, Intravenous); By End User (Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Basal Cell Carcinoma ( BCC ) Treatment Market will witness a robust CAGR of 6.8% , valued at $6.4 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485
In-vitro Diagnostics Enzymes Market By Type (Polymerases & Nucleases, Proteases, Carbohydrases, Others); By Application (Molecular Diagnostics, Clinical Chemistry, Immunoassays, Hematology, Others); By End User (Hospitals & Diagnostic Labs, Academic & Research Institutes, POC Testing Centers, Pharma & Biotech Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global In-Vitro Diagnostics ( IVD ) Enzymes Market will witness a robust CAGR of 8.6% , valued at $1.93 billion in 2024 , expected to appreciate... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485
Vaccine Contract Manufacturing Market By Service Type (Formulation and Fill-Finish, API Production, Packaging); By Vaccine Type (mRNA, Recombinant, Inactivated); By End User (Biopharma, Governments); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Vaccine Contract Manufacturing Market will witness a robust CAGR of 9.2% , valued at $4.4 billion in 2024 , and is expected to appreciate and reach $8.2 billion by... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485
Liposomal Doxorubicin Market By Product Type (Conventional Liposomal Doxorubicin, PEGylated Liposomal Doxorubicin, Non-PEGylated Liposomal Doxorubicin); By Cancer Type (Breast Cancer, Ovarian Cancer, Kaposi’s Sarcoma, Multiple Myeloma, Other Solid Tumors); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Liposomal Doxorubicin Market will witness a robust CAGR of 6.9% , valued at $1.42 billion in 2024 , expected to appreciate and reach $2.13 billion... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485
Metabolic Disorder Therapeutics Market By Product Type (Insulin and Insulin Analogs, Enzyme Replacement Therapies, Gene Therapies, RNA-Based Therapeutics, Small Molecule Drugs, Other Biologics); By Application (Diabetes Mellitus, Obesity, Lysosomal Storage Disorders, Hypercholesterolemia and Dyslipidemia, Other Metabolic Disorders); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metabolic Disorder Therapeutics Market will witness a robust CAGR of 7.4% , valued at USD 72.6 billion in 2024 , expected to appreciate and reach USD 112.5 billion... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485
Allergy Immunotherapy Market By Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy); By Allergy Type (Allergic Rhinitis, Asthma, Venom Allergy, Food Allergy, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Allergy Immunotherapy Market will witness a robust CAGR of 11.3 % , valued at $2.49 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485
Pediatric Vaccines Market By Vaccine Type (Inactivated, Live Attenuated, Conjugate, Toxoid, Subunit/Recombinant, mRNA); By Disease Indication (MMR, DTaP, Polio, Pneumococcal, Hepatitis, Rotavirus, Hib, Others); By Route of Administration (Intramuscular, Subcutaneous, Oral); By Distribution Channel (Public Programs, Private Clinics, Hospitals, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Pediatric Vaccines Market will witness a robust CAGR of approximately 6.4%, valued at USD 49.3 billion in 2024, expected to appreciate and reach USD 73.9 billion by 2030, confirms Strategic Market Research.Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485
Osteoarthritis Therapeutics Market By Drug Class (NSAIDs, Corticosteroids, Viscosupplements, Biologics, DMOADs); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Osteoarthritis Therapeutics Market is projected to grow at a robust CAGR of 9.3 % , reaching an estimated value of $ 16.42Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485
Burn Ointment Market By Product Type (Antimicrobial Burn Ointments, Moisturizing Burn Creams, Pain-Relief Burn Gels, Regenerative and Bioactive Formulations); By Burn Severity (Minor Burns, Partial-Thickness Burns, Full-Thickness Burns); By End User (Hospitals, ASCs, Retail Pharmacies and Online, Military and Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Burn Ointment Market will witness a robust CAGR of 6.4% , valued at $1.45 billion in 2024 , expected to appreciate and reach $ 2.5 Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485
Non-Alcoholic Steatohepatitis (NASH) Treatment Market By Drug Type (Vitamin E & Pioglitazone, Obeticholic Acid, Elafibranor, Selonsertib, Other Pipeline Molecules); By Mechanism of Action (Anti-fibrotic Agents, Anti-inflammatory Agents, Metabolic Modulators); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Alcoholic Steatohepatitis ( NASH ) Treatment Market will witness a robust CAGR of 19.3 % , valued at $5.2 bi... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485
Cholera Vaccines Market By Vaccine Type (Killed/Inactivated, Live Attenuated); By End User (Public Health Agencies, NGOs, Hospitals & Clinics, Military & Travelers); By Route of Administration (Oral, Parenteral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cholera Vaccines Market will witness a robust CAGR of 8.7% , valued at $113.4 million in 2024 , and is expected to appreciate and reach $186.2 million by 2030Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485
Enteric Empty Capsules Market By Material Type (Gelatin Capsules, Non-Gelatin Capsules [HPMC and Others]); By Release Mechanism (pH-Dependent Release, Time-Dependent Release, Enzyme-Triggered Release); By End User (Pharmaceutical Companies, Nutraceutical Companies, CMOs/CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Enteric Empty Capsules Market will witness a robust CAGR of 4.56 % , valued at USD 995 million in 2024, expected to appreciate and reach about USD... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485
Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market By Product Type (Non-Selective COX Inhibitors, COX-2 Selective Inhibitors, Salicylates); By Route of Administration (Oral, Topical, Parenteral); By Application (Osteoarthritis, Rheumatoid Arthritis, Acute Pain, Chronic Back Pain, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Steroidal Anti-Inflammatory Drugs Market will witness a robust CAGR of 9.78 % , valued at $ 11.23 billion in 2024 , ... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485
Catastrophic Antiphospholipid Syndrome Market By Treatment Modality (Plasma Exchange, Anticoagulation Therapy, Immunosuppressive Agents, Intravenous Immunoglobulins, Complement Inhibitors); By Diagnostic Approach (ELISA, Lupus Anticoagulant Testing, Beta-2 Glycoprotein I Testing, Next-Generation Sequencing); By End User (Hospitals & Critical Care Centers, Specialty Clinics & Immunology Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Catastrophic Antiphospholipid Syndrome ( CAPS ) Market will witness a robust CAGR of 7.4% , valued at $654 million in 2024Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485
Rheumatoid Arthritis Therapeutics Market By Drug Class (Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs, NSAIDs, Corticosteroids); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rheumatoid Arthritis Therapeutics Market will witness a robust CAGR of 6.8% , valued at $28.4 billion in 2024 , and is expected to appreciate and reach $42.1 billi... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485
Nanocapsules Market By Material Type (Polymeric Nanocapsules, Lipid-Based Nanocapsules, Hybrid Nanocapsules); By Application (Pharmaceuticals, Cosmetics & Personal Care, Food & Nutraceuticals, Agrochemicals, Others); By End User (Pharmaceutical & Biotechnology Companies, Cosmetic Manufacturers, Food & Beverage Companies, Agriculture Sector, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nanocapsules Market will witness a robust CAGR of 13.8% valued at $3.9 billion in 2024, expected to appreciate and reach $8.6 bil... Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485
Guillain-Barre Syndrome Market By Treatment Type (IVIG, Plasmapheresis, Steroid Therapy, Supportive Care); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Hospitals, Neurology Clinics, ASCs, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Guillain - Barré Syndrome ( GBS ) Market will witness a robust CAGR of ... Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485
Huntington’s Disease Treatment Market By Treatment Type (Symptomatic Treatment, Disease-Modifying Therapies); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Huntington’s Disease Treatment Market will witness a robust CAGR of 21.1% , valued at $1.3 billion in 2024 , and is expected to app... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485
Antifungal Drugs Market By Drug Type (Azoles, Echinocandins, Polyenes, Allylamines, Others); By Indication (Superficial Fungal Infections, Systemic Fungal Infections); By Route of Administration (Oral, Topical, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Antifungal Drugs Market will witness a robust CAGR of 5.7% , valued at approximately $16.3 billion in 2024 , and is expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:162 | $ 4485
Migraine Drugs Market By Drug Type (Abortive Drugs [Triptans, CGRP Receptor Antagonists, NSAIDs, Ergot Alkaloids]; Preventive Drugs [Beta-Blockers, Antiepileptic Drugs, CGRP Monoclonal Antibodies, Antidepressants]); By Route of Administration (Oral, Injectable, Nasal Spray, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Migraine Drugs Market will witness a robust CAGR of 8.2 % , valued at $7.9 billion in 2024 , and is expected to appreciate significantly ... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485
Peptide Antibiotics Market By Product Type (Natural Peptides, Synthetic Peptides); By Application (Hospital-Acquired Infections, Skin and Soft Tissue Infections, Others); By End User (Hospitals and Clinics, Pharmaceutical Companies, Research Institutes); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peptide Antibiotics Market will witness a robust CAGR of 9.2% , valued at USD 1.85 billion in 2024, expected to appreciate and reach USD 3.19 bill... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485
Endometriosis Treatment Market By Treatment Type (Hormonal Therapy, Pain Management, Surgery); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endometriosis Treatment Market will witness a robust CAGR of 7.6% , valued at USD 2.45 billion in 2024, expected to appreciate and reach USD 3.82 ... Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485
Human Papillomavirus (HPV) Vaccine Market By Vaccine Type (Bivalent, Quadrivalent, Nonavalent); By Age Group (9–14 Years, 15–26 Years, Above 26 Years); By Distribution Channel (Government Supplies, Private Clinics & Hospitals, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Human Papillomavirus ( HPV ) Vaccine Market will witness a robust CAGR of 6.8% , valued at $5.2 billion in 2024 , expect... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485
Somatostatin Analogs Market By Product Type (Short-Acting, Long-Acting); By Indication (Acromegaly, Neuroendocrine Tumors, Cushing’s Disease, Others); By Route of Administration (Intramuscular, Subcutaneous, Intravenous); By Distribution Channel (Hospitals, Specialty Clinics, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Globa l Somatostatin Analogs Market will witness a robust CAGR of 6.4% , valued at $4.2 billion in 2024 , expe... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485
Microbial Identification Market By Product Type (Instruments, Consumables & Reagents, Software & Services); By Method (Phenotypic, Molecular, Mass Spectrometry); By End User (Hospitals & Clinical Labs, Pharmaceutical & Biotech Companies, Food & Beverage Labs, Environmental Testing Facilities, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Microbial Identification Market will witness a robust CAGR of 9.2% , valued at $ 4.5 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485
Intravenous Iron Drugs Market By Product Type (Ferric Carboxymaltose, Iron Sucrose, Ferumoxytol, Ferric Derisomaltose, Others); By Application (Chronic Kidney Disease, Iron Deficiency Anemia in Non-Dialysis Patients, Oncology and Chemotherapy-Induced Anemia, Gastroenterology, Women’s Health, Surgery and Perioperative Care); By End User (Hospitals, Outpatient Clinics and Infusion Centers, Dialysis Centers, Specialty Care Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Intravenous Iron Drugs Market will witness a robust CAGR of 8.2% , valued at USD 2.25 billion in 2024, expected to appreciate and reach USD 3.61 b... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485
Exosomes Market By Product Type (Isolation & Purification Kits, Instruments & Analyzers, Labeling & Detection Kits, Services); By Application (Cancer Diagnostics & Prognostics, Drug Delivery, Regenerative Medicine, Neurodegenerative Disorders, Others); By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Exosomes Market will witness a robust CAGR of 19.2% , valued at $1.4 billion in 2024 , expected to appreciate and reach $4.0 billion by 2030 , confirms St... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485
Acromegaly Treatment Market By Drug Class (Somatostatin Analogs, Growth Hormone Receptor Antagonists, Dopamine Agonists, Emerging Therapies); By Route of Administration (Injectable, Oral); By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Homecare & Tele-Endocrinology); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acromegaly Treatment Market will witness a steady CAGR of 5.8% , valued at $2.1 billion in 2024 , expected to appreciate and reach $3.1 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485
Molecular Weight Marker Market By Product Type (DNA Markers, Protein Markers, RNA Markers, Prestained Markers, Unstained Markers, Custom/Hybrid Markers); By Application (Genomics and Transcriptomics, Proteomics, Disease Diagnosis, Drug Development, Forensic Analysis, Others); By End User (Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, Clinical Diagnostic Laboratories, CROs, Forensic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Molecular Weight Marker Market will witness a robust CAGR of 6.9% , valued at $525.3 million in 2024 , expected to appreciate and reach $832.1 million by 2030Read More

Published Date: OCT-2025 | No Of Pages:173 | $ 4485
Acute Repetitive Seizures Market By Product Type (Intranasal Rescue Therapies, Buccal and Sublingual Formulations, Injectable Rescue Medications); By Route of Administration (Nasal, Oral/Buccal, Intramuscular/Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Repetitive Seizures Market will witness a robust CAGR of 13.1% , valued at approximately $805 million in 2024 , expected to appreciate and reach around $1.67... Read More

Published Date: OCT-2025 | No Of Pages:181 | $ 4485
Cancer Gene Therapy Market By Therapy Type (Gene Transfer Therapy, Oncolytic Virotherapy, Gene Editing Therapy); By Vector Type (Viral Vectors, Non-Viral Vectors); By Cancer Indication (Hematological Malignancies, Breast Cancer, Lung Cancer, Others); By End User (Hospitals and Cancer Centers, Academic Institutions, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer Gene Therapy Market will witness a robust CAGR of 25.8 % , valued at USD 2.9 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485
Postmenopausal Osteoporosis Treatment Market By Drug Class (Bisphosphonates, RANK Ligand Inhibitors, SERMs, Parathyroid Hormone Analogs, Calcitonin & Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context


The Global Postmenopausal Osteoporosis Treatment Market will witness a robust CAGR of 6.9%, valued at $14.63 billion in 2024, expected to appreciate and reach $22.42 ... Read More

Published Date: OCT-2025 | No Of Pages:183 | $ 4485
Pneumonia Therapeutics Market By Drug Class (Antibiotics, Antivirals, Antifungals, Monoclonal Antibodies, Adjunct Therapies); By Etiology (Bacterial, Viral, Fungal, Aspiration, Atypical); By Route of Administration (Oral, Intravenous, Inhalation); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pneumonia Therapeutics Market will witness a robust CAGR of 6.4 % , valued at $17.3 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485
Dialysis Concentrates Market By Product Type (Acid Concentrates, Bicarbonate Concentrates); By Formulation (Liquid, Powder/Dry); By End User (In-Center Dialysis Clinics, Hospitals, Home Dialysis Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dialysis Concentrates Market will witness a robust CAGR of 6.1% , valued at $2.94 billion in 2024 , expected to appreciate and reach $4.19 billion by 2030... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485
Insomnia Therapeutics Market By Treatment Type (Prescription Medications [Non-benzodiazepine Hypnotics, Benzodiazepines, Melatonin Receptor Agonists, Orexin Receptor Antagonists], Over-the-Counter Sleep Aids, Digital and Behavioral Therapeutics); By Route of Administration (Oral, Transdermal, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Insomnia Therapeutics Market will witness a robust CAGR of 6.8% , valued at $4.9 billion in 2024 , expected to appreciate and reach $7.3 billion by 2030 ,... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485
Keytruda (Pembrolizumab) Market By Cancer Type (NSCLC, Melanoma, Colorectal, Bladder, Head & Neck, Others); By Route of Administration (Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Keytruda (Pembrolizumab) Market will witness a strong CAGR of 12.4% , valued at $26.3 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485
Protein Sequencing Market By Technology (Mass Spectrometry, Edman Degradation, De Novo Sequencing); By Application (Biopharmaceutical Drug Development, Disease Biomarker Identification, Antibody Characterization, Proteogenomics); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, CROs, Clinical Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Protein Sequencing Market will witness a robust CAGR of 13.2%, valued at $1.35 billion in 2024 , and is expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485
Fondaparinux Market By Dosage Strength (2.5 mg/0.5 ml, 5 mg/0.4 ml, 7.5 mg/0.6 ml, 10 mg/0.8 ml); By Indication (DVT, PE, ACS, HIT, Orthopedic Surgery); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Fondaparinux Market will witness a moderate yet stable CAGR of 7.3% , valued at USD 643.2 million in 2024 , and is expected to grow stead... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485
Biological Data Visualization Market By Product Type (Software Solutions, Services); By Application (Genomics And Transcriptomics Visualization, Proteomics And Metabolomics Visualization, Drug Discovery And Development, Epidemiology And Population Studies); By End User (Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Healthcare Providers And Clinical Labs, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Biological Data Visualization Market will witness a robust CAGR of 12.3% , valued at $1.85 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485
Actinic Keratosis Treatment Market By Treatment Type (Topical Medications, Cryotherapy, Photodynamic Therapy, Laser Therapy, Others); By End User (Hospitals and Dermatology Clinics, Ambulatory Surgical Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Actinic Keratosis Treatment Market will witness a robust CAGR of 6.8% , valued at $7.2 billion in 2024 , and is expected to appreciate an... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485
Measles, Mumps, and Rubella Vaccine Market By Product Type (Monovalent, MMR Combination, MMRV); By Route of Administration (Subcutaneous); By Distribution Channel (Public Sector, Private Sector); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Measles, Mumps, And Rubella (MMR) Vaccine Market will witness a steady CAGR of 5.8% , valued at $3.1 billion in 2024 , and is projected t... Read More

Published Date: OCT-2025 | No Of Pages:190 | $ 4485
Nucleotide Market By Type (Mononucleotides, Dinucleotides, Oligonucleotides, Cyclic Nucleotides, Modified Nucleotides); By Application (Pharmaceuticals and Drug Development, Nutraceuticals and Functional Foods, Molecular Biology and Genetic Engineering, Diagnostics and Biosensing, Veterinary and Animal Nutrition); By End User (Pharmaceutical and Biotech Companies, Academic and Research Institutions, CDMOs, Food & Beverage Manufacturers, Veterinary Product Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nucleotide Market will witness a robust CAGR of 9.2%, valued at $843.2 million in 2024 , expected to appreciate and reach $<... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485
Paroxysmal Nocturnal Hemoglobinuria Market By Drug Type (C5 Inhibitors, C3 Inhibitors, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Market will witness a robust CAGR of 9.7 % ,... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485
Hemophilia Treatment Market By Product Type (Plasma-Derived Coagulation Factor Concentrates, Recombinant Coagulation Factors, Non-Factor Replacement Therapies, Gene Therapy); By Disease Type (Hemophilia A, Hemophilia B, Others); By Treatment Approach (On-Demand Therapy, Prophylactic Therapy, Immune Tolerance Induction Therapy); By End User (Hospitals & Hemophilia Treatment Centers, Home Care Settings, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemophilia Treatment Market will witness a robust CAGR of 8.78 % , valued at $10.45 billionRead More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485
Dementia Treatment Market By Treatment Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Monoclonal Antibodies, Combination Therapies, Others); By Route of Administration (Oral, Intravenous, Transdermal); By End User (Hospitals and Memory Clinics, Homecare Settings, Long-Term Care Facilities, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dementia Treatment Market will witness a robust CAGR of 12.8% , valued at $10.45 billion in 2024 , expected to appreciat... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485
Lab-on-a-Chip Market By Product Type (Instruments, Reagents & Consumables, Software and Data Management Systems); By Application (Clinical Diagnostics, Drug Discovery and Development, Genomics and Proteomics, Environmental Testing, Others); By End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Environmental and Food Testing Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lab-On-A-Chip Market will witness a robust CAGR of 8.5 % , valued at $7.6 billion in 2024 , and is expected to appreciate and reach $Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485
Anxiety Disorder Treatment Market By Drug Class (SSRIs, SNRIs, Benzodiazepines, Beta-Blockers, Atypical Antipsychotics); By Therapy Type (CBT, Digital Therapeutics, Exposure Therapy, MBSR); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Mental Health Clinics, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anxiety Disorder Treatment Market will witness a robust CAGR of 7.8% , valued at $12.4 billion in 2024 , and is expected to appreciate and reach $19.6 billion by 2... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485
Myeloproliferative Disorder Treatment Market By Disorder Type (PV, ET, PMF); By Treatment (JAK Inhibitors, Chemotherapy, Stem Cell Transplantation); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital, Retail, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Myeloproliferative Disorder Treatment Market is expected to witness a steady CAGR of 6.9% , valued at $5.4 billion in 2024 , and projected to reach $8.1 billion by... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485
Ophthalmic Drugs Market By Drug Class (Anti-Glaucoma Drugs, Anti-Inflammatory Drugs, Anti-Infective Drugs, Anti-Allergy Drugs, Retinal Disorder Therapies); By Route of Administration (Topical, Injectable, Oral, Ocular Inserts); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ophthalmic Drugs Market will witness a robust CAGR of 6.9% , valued at $35.65 billion in 2024 , expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485
Pancreatic Cancer Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiotherapy, Others); By Disease Stage (Localized, Locally Advanced, Metastatic); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pancreatic Cancer Treatment Market will witness a robust CAGR of 11.8% , valued at USD 6.4 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485
Anterior Uveitis Treatment Market By Treatment Type (Corticosteroids, Cycloplegics, Biologics, Immunosuppressants, NSAIDs); By Route of Administration (Topical, Oral, Parenteral, Implants); By End User (Hospitals, Specialty Clinics, ASCs, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anterior Uveitis Treatment Market will witness a robust CAGR of 6.9% , valued at $494.7 million in 2024 , expected to appreciate and reac... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485
Gastroesophageal Reflux Disease (GERD) Therapeutics Market Gastroesophageal Reflux Disease Therapeutics Market By Drug Class (PPIs, H2 Receptor Antagonists, Antacids, Prokinetics, Mucosal Protectants); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market is projected to grow at a robust CAGR of 5.7% , increasing from USD 7.... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485
Inflammatory Bowel Disease (IBD) Treatment Market By Drug Class (Biologics [TNF-alpha Inhibitors, Integrin Inhibitors, Interleukin Inhibitors], Small Molecules [JAK Inhibitors, S1P Receptor Modulators], 5-ASA Derivatives, Corticosteroids, Immunomodulators, Others); By Disease Type (Crohn’s Disease, Ulcerative Colitis); By Route of Administration (Oral, Injectable, Rectal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Inflammatory Bowel Disease (IBD) Treatment Market will witness a robust CAGR of 6.9% , valued at $24.8 billion in 2024 ,... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485
Spheroids Market By Technology Type (Scaffold-Based, Scaffold-Free); By Application (Cancer Research, Drug Discovery & Toxicology Testing, Stem Cell Research, Regenerative Medicine, Tissue Engineering); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs, Hospitals & Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Spheroids Market will witness a robust CAGR of 18.3% , valued at $802 million in 2024, and is expected to reach nearly $2.18 billion by 2030 , confirms St... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485
Small Molecule API Market By Type (Innovative APIs, Generic APIs); By Manufacturing Method (In-house, Outsourced); By Therapeutic Application (Oncology, Cardiovascular, CNS, Infectious Diseases, Respiratory, Diabetes, Others); By End User (Pharmaceutical Companies, Biopharmaceutical Firms, CDMOs, Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule API Market will witness a robust CAGR of 6.9%, valued at $203.4 billion in 2024 , and is expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485
Metastatic Lung Adenocarcinoma Treatment Market By Therapy Type (Targeted Therapy, Immunotherapy, Chemotherapy, Radiotherapy, Combination Therapy); By Biomarker Status (EGFR Mutation, ALK Rearrangement, KRAS Mutation, PD-L1 Expression, Wild-Type); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Metastatic Lung Adenocarcinoma Treatment Market will witness a robust CAGR of 9.2% , valued at $12.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485
Neuroendocrine Tumor (NET) Treatment Market By Treatment Type (Somatostatin Analogs, Targeted Therapy, PRRT, Chemotherapy, Immunotherapy, Surgery); By Indication (GI NETs, Pancreatic NETs, Lung NETs, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neuroendocrine Tumor (NET) Treatment Market will witness a robust CAGR of 8.7% , value... Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485
Gabapentin Market By Product Type (Generic, Branded); By Route of Administration (Oral Capsules/Tablets, Oral Solution, Others); By Indication (Epilepsy, Neuropathic Pain, Fibromyalgia, Off-Label Uses); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gabapentin Market will witness a robust CAGR of 6.4% , valued at $2.87 billion in 2024 , and is expected to appreciate and reach ... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485
Microbiology Culture Market By Type of Culture Media (Complex Media, Synthetic Media, Specialty Media, Enriched and Selective Media); By Application (Clinical Testing, Pharmaceutical Production, Food and Water Testing, Environmental Microbiology, Research); By End User (Hospitals & Labs, Biotech & Pharma Companies, Food Manufacturers, Research Institutes, Environmental Testing Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Microbiology Culture Market will witness a robust CAGR of 8.3% , valued at $5.3 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:177 | $ 4485
Drug Discovery Informatics Market By Solution Type (Software, Services); By Function (Sequence Analysis, Molecular Modeling, Docking, Target Data Analysis, Lead Optimization, Others); By Deployment Mode (On-premise, Cloud-Based); By End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Drug Discovery Informatics Market will witness a robust CAGR of 12.3 %, valued at USD 5.36 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485
Herceptin Biosimilars Market By Product Type (Single-Agent, Combination-Ready, Lyophilized, Liquid); By Indication (HER2+ Breast Cancer, HER2+ Gastric Cancer); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herceptin Biosimilars Market will witness a robust CAGR of 16.2%, valued at $1.84 billion in 2024 ... Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485
Peptide Drug Conjugates Market By Product Type (Cytotoxic, Radiolabeled, Peptide-Oligonucleotide, Multivalent); By Application (Oncology, Autoimmune, Metabolic, Infectious, Neurological); By Route of Administration (IV, SC, IM, Oral); By End User (Hospitals, Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peptide Drug Conjugates Market will witness a robust CAGR of 24.2% , valued at $1.73 billion in 2024 , expected to appreciate and reach $6.42 bill... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485
Inhalation Anesthesia Market By Product Type (Sevoflurane, Isoflurane, Desflurane, Nitrous Oxide); By Application (Maintenance Anesthesia, Induction Anesthesia, Sedation); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context


The Global Inhalation Anesthesia Market will witness a robust CAGR of 6.8%, valued at $2.4 billion in 2024, expected to appreciate and reach $3.99 billion by 2030, confirms Strategic Market Research.... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485
Automated NGS Library Preparation Market By Product Type (Automated Instruments, Reagents & Consumables, Software & Informatics Solutions); By Application (Oncology Research and Diagnostics, Genetic Disease and Rare Disorder Analysis, Infectious Disease Surveillance, Agrigenomics, Other Research Applications); By End User (Clinical Laboratories and Diagnostic Centers, Research Institutions and Academic Labs, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Agrigenomics and Food Safety Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Automated NGS Library Preparation Market will witness a robust CAGR of 13.2% , valued at approximately $970 million in 2024Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485
Transthyretin Amyloidosis Treatment Market By Drug Type (RNA Interference, Antisense Oligonucleotides, TTR Stabilizers, Supportive Therapies); By Route of Administration (Intravenous, Oral, Others); By End User (Hospitals & Specialty Clinics, Outpatient & Home Care, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Transthyretin Amyloidosis Treatment Market will witness a robust CAGR of 13.8% , valued at USD 2.1 billion in 2024, expe... Read More

Published Date: OCT-2025 | No Of Pages:168 | $ 4485
Non-Viral Transfection Reagents Market By Product Type (Lipid-Based, Polymer-Based, Protein-Based, Others); By Application (Gene Expression, RNAi, Genome Editing, Protein Production, Therapeutic Delivery); By End User (Pharma & Biotech, Academic Institutes, CROs, Clinical Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Non-Viral Transfection Reagents Market will witness a robust CAGR of 10.2% , valued at $1.1 billion in 2024 , and is expected to appreciate and reach $2.17 billion... Read More

Published Date: OCT-2025 | No Of Pages:165 | $ 4485
Aminoglycosides Market By Drug Type (Gentamicin, Amikacin, Tobramycin, Neomycin, Streptomycin, Others); By Route of Administration (Injectable, Topical, Oral); By Application (Human Health, Veterinary Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Aminoglycosides Market will witness a robust CAGR of 5.8% , valued at $1.24 billion in 2024 , and is expected to appreciate and reach $1.74 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485
Pharmaceutical Analytical Testing Outsourcing Market By Service Type (Bioanalytical Testing Services, Method Development and Validation, Stability Testing, Raw Material Testing, Microbiological Testing, Others); By End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, Academic and Research Institutes); By Molecule Type (Small Molecules, Large Molecules); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pharmaceutical Analytical Testing Outsourcing Market will witness a robust CAGR of 8.9% , valued at approximately $7.2 billionRead More

Published Date: OCT-2025 | No Of Pages:158 | $ 4485
Infectious Disease Therapeutics Market By Product Type (Antiviral Drugs, Antibacterial Drugs, Antifungal and Antiparasitic Drugs, Monoclonal Antibodies and Immunotherapies); By Indication (HIV/AIDS, Hepatitis, Influenza, Tuberculosis, Malaria, Others); By Route of Administration (Oral, Parenteral, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Infectious Disease Therapeutics Market will witness a robust CAGR of 7.4% , valued at approximately $145.6 billion in 2024 , and is expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485
Biopharmaceutical Manufacturing Consumables Testing Market By Testing Type (Sterility & Contamination Testing, Extractables and Leachables Testing, Particulate and Integrity Testing, Endotoxin and Pyrogen Testing, Functional Performance Testing); By Consumable Type (Single-Use Bioreactor Bags, Sterile Filters, Tubing & Connectors, Sampling Systems, Other Disposable Assemblies); By End User (Biopharmaceutical Manufacturers, CMOs, Academic & Research Institutes, Regulatory Testing Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Biopharmaceutical Manufacturing Consumables Testing Market will witness a robust CAGR of 10.8%, valued at $4.2 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485
Dopamine Agonist Market By Product Type (Ergot-Derived, Non-Ergot); By Route of Administration (Oral, Transdermal, Injectable); By Indication (Parkinson’s Disease, Restless Leg Syndrome, Hyperprolactinemia, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dopamine Agonist Market will witness a robust CAGR of 6.5 % , valued at $3.4 billion in 2024 , expected to appreciate and reach $... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485
Forensic Genomics Market By Technology (Next-Generation Sequencing, Capillary Electrophoresis, PCR-Based Assays, Microarray-Based Genotyping); By Application (Criminal Casework, Missing Persons Identification, Disaster Victim Identification, Biodefense, Genealogical Research); By End User (Forensic Laboratories, Law Enforcement Agencies, Academic Institutions, Government Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Forensic Genomics Market will witness a robust CAGR of 13.7%, valued at $1.82 billion in 2024, expected to appreciate and reach $4.42 billion by 2030, con... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485
Tetanus Toxoid Vaccine Market By Product Type (Monovalent, Combination Vaccines); By Age Group (Pediatric, Adolescent & Adult); By Distribution Channel (Public Health Programs, Private Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tetanus Toxoid Vaccine Market will witness a robust CAGR of 5.5% , valued at approximately USD 2.4 billion in 2024 , and is expected to a... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485
Small Scale Bioreactors Market By Product Type (Single-Use Bioreactors, Stainless Steel Bioreactors); By Application (Process Development, Preclinical and Clinical Trials, Academic Research); By End User (Biopharmaceutical Companies, CDMOs, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Small Scale Bioreactors Market will witness a robust CAGR of 12.4% (inferred), valued at $500 million in 2024, expected to appreciate and reach $2.5 billion by 2030, confirms Strategic Market Research.Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485
Sepsis Therapeutics Market By Drug Class (Antibiotics & Antimicrobials, Immunomodulators & Biologics, Adjuvant Therapies); By Pathogen Type (Gram-Negative Bacteria, Gram-Positive Bacteria, Fungal Infections); By Route of Administration (Intravenous, Oral); By End User (Hospitals & ICUs, Specialty Clinics & Research Institutions, Military & EMS); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sepsis Therapeutics Market will witness a robust CAGR of 8.4% , valued at $5.1 billion in 2024 , expected to appreciate and reach $8.3 billion by ... Read More

Published Date: OCT-2025 | No Of Pages:194 | $ 4485
Dermatological Drugs Market By Drug Class (Corticosteroids, Retinoids, Anti-infectives, Calcineurin Inhibitors, Biologics, Others); By Indication (Acne, Psoriasis, Atopic Dermatitis, Rosacea, Skin Infections, Skin Cancer, Others); By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dermatological Drugs Market will witness a robust CAGR of 8.1%, valued at $27.6 billion in 2024, expected to appreciate and reach $46.3 billion ... Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485
Viral Inactivation Market By Method Type (Solvent/Detergent Method, Low pH Treatment, UV Treatment, Pasteurization, Others); By Application (Blood and Plasma Products, Vaccines, Cell and Gene Therapy Products, Recombinant Proteins, Tissue & Stem Cell Products); By End User (Pharmaceutical & Biopharmaceutical Companies, CMOs/CROs, Academic & Research Institutions, Government & Regulatory Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Viral Inactivation Market will witness a robust CAGR of 10.4 % , valued at $ 3.56 billion in 2024 , and... Read More

Published Date: OCT-2025 | No Of Pages:185 | $ 4485
Cell-Free Protein Expression Market By Product Type (Reagents, Expression Systems, Templates); By Application (Protein Engineering, High-Throughput Screening, Enzyme Engineering, Diagnostics, Synthetic Biology & Biomanufacturing); By End User (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, CROs, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell-Free Protein Expression Market will witness a robust CAGR of 7.8% , valued at $275.3 million in 2024 , and is expected to appreciate and reach $463.1 million ... Read More

Published Date: OCT-2025 | No Of Pages:176 | $ 4485
Cancer Stem Cells Market By Product Type (Targeted Therapies, Cell-Based Therapies, Others); By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Other Cancers); By End User (Hospitals & Cancer Treatment Centers, Academic & Research Institutes, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Stem Cells Market will witness a robust CAGR of 7.92 % , valued at $1.6 billion in 2024 , expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485
Cell Culture Vessels Market By Product Type (Cell Culture Flasks, Cell Culture Dishes and Plates, Roller Bottles, Bioreactors and Cell Culture Bags, Other Vessels); By Material (Polystyrene, Polycarbonate, Glass); By Application (Biopharmaceutical Production, Cell & Gene Therapy Manufacturing, Academic & Research Labs, Stem Cell Research, Tissue Engineering and Regenerative Medicine); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cell Culture Vessels Market will witness a robust CAGR of 7.8% , valued at USD 2.6 billion in 2024, expected to appreciate and reach USD 4.1 billi... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485